日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/22 | 7,530 | 7,550 | 7,460 | 7,520 | +30 | +0.4% | 167,400 |
| 2022/12/21 | 7,450 | 7,600 | 7,400 | 7,490 | +20 | +0.3% | 152,600 |
| 2022/12/20 | 7,670 | 7,720 | 7,420 | 7,470 | -210 | -2.7% | 248,200 |
| 2022/12/19 | 7,790 | 7,790 | 7,650 | 7,680 | -130 | -1.7% | 135,000 |
| 2022/12/16 | 7,930 | 7,930 | 7,760 | 7,810 | -190 | -2.4% | 187,800 |
| 2022/12/15 | 8,050 | 8,050 | 7,980 | 8,000 | -20 | -0.2% | 107,000 |
| 2022/12/14 | 7,990 | 8,040 | 7,940 | 8,020 | +90 | +1.1% | 153,100 |
| 2022/12/13 | 7,900 | 7,980 | 7,870 | 7,930 | +60 | +0.8% | 155,800 |
| 2022/12/12 | 7,860 | 7,910 | 7,810 | 7,870 | -30 | -0.4% | 124,200 |
| 2022/12/09 | 7,630 | 7,900 | 7,630 | 7,900 | +190 | +2.5% | 244,300 |
| 2022/12/08 | 7,830 | 7,840 | 7,640 | 7,710 | -80 | -1% | 214,800 |
| 2022/12/07 | 7,690 | 7,830 | 7,660 | 7,790 | +40 | +0.5% | 232,800 |
| 2022/12/06 | 7,740 | 7,840 | 7,700 | 7,750 | ±0 | ±0% | 207,800 |
| 2022/12/05 | 7,770 | 7,790 | 7,670 | 7,750 | +10 | +0.1% | 241,900 |
| 2022/12/02 | 7,810 | 7,810 | 7,720 | 7,740 | -140 | -1.8% | 394,700 |
| 2022/12/01 | 8,090 | 8,090 | 7,770 | 7,880 | -210 | -2.6% | 607,900 |
| 2022/11/30 | 8,220 | 8,240 | 8,060 | 8,090 | -230 | -2.8% | 526,100 |
| 2022/11/29 | 8,520 | 8,530 | 8,280 | 8,320 | -280 | -3.3% | 258,100 |
| 2022/11/28 | 8,700 | 8,770 | 8,570 | 8,600 | -190 | -2.2% | 204,100 |
| 2022/11/25 | 8,830 | 8,850 | 8,700 | 8,790 | +30 | +0.3% | 200,100 |
| 2022/11/24 | 8,780 | 8,880 | 8,700 | 8,760 | +90 | +1% | 192,100 |
| 2022/11/22 | 8,670 | 8,760 | 8,640 | 8,670 | +150 | +1.8% | 124,200 |
| 2022/11/21 | 8,620 | 8,640 | 8,490 | 8,520 | -50 | -0.6% | 80,000 |
| 2022/11/18 | 8,470 | 8,600 | 8,460 | 8,570 | +100 | +1.2% | 161,100 |
| 2022/11/17 | 8,450 | 8,570 | 8,440 | 8,470 | +60 | +0.7% | 99,400 |
| 2022/11/16 | 8,600 | 8,600 | 8,370 | 8,410 | -200 | -2.3% | 162,200 |
| 2022/11/15 | 8,630 | 8,680 | 8,550 | 8,610 | +120 | +1.4% | 177,100 |
| 2022/11/14 | 8,330 | 8,620 | 8,300 | 8,490 | +160 | +1.9% | 291,300 |
| 2022/11/11 | 8,110 | 8,540 | 8,090 | 8,330 | +410 | +5.2% | 368,100 |
| 2022/11/10 | 7,900 | 8,010 | 7,840 | 7,920 | -20 | -0.3% | 132,600 |
| 2022/11/09 | 7,990 | 8,020 | 7,860 | 7,940 | -90 | -1.1% | 125,400 |
| 2022/11/08 | 7,950 | 8,080 | 7,930 | 8,030 | +100 | +1.3% | 88,400 |
| 2022/11/07 | 7,980 | 8,030 | 7,920 | 7,930 | -50 | -0.6% | 126,600 |
| 2022/11/04 | 8,090 | 8,120 | 7,950 | 7,980 | -160 | -2% | 150,900 |
| 2022/11/02 | 8,100 | 8,210 | 7,990 | 8,140 | -30 | -0.4% | 170,400 |
| 2022/11/01 | 8,230 | 8,300 | 8,140 | 8,170 | -70 | -0.8% | 140,800 |
| 2022/10/31 | 8,140 | 8,340 | 8,140 | 8,240 | +160 | +2% | 316,100 |
| 2022/10/28 | 7,940 | 8,170 | 7,900 | 8,080 | ±0 | ±0% | 524,300 |
| 2022/10/27 | 7,820 | 8,300 | 7,790 | 8,080 | +470 | +6.2% | 682,100 |
| 2022/10/26 | 7,560 | 7,650 | 7,520 | 7,610 | +200 | +2.7% | 138,900 |
| 2022/10/25 | 7,460 | 7,470 | 7,390 | 7,410 | +10 | +0.1% | 95,600 |
| 2022/10/24 | 7,560 | 7,590 | 7,380 | 7,400 | -50 | -0.7% | 77,800 |
| 2022/10/21 | 7,500 | 7,500 | 7,410 | 7,450 | -60 | -0.8% | 122,300 |
| 2022/10/20 | 7,600 | 7,670 | 7,430 | 7,510 | -160 | -2.1% | 282,000 |
| 2022/10/19 | 7,700 | 7,760 | 7,660 | 7,670 | ±0 | ±0% | 131,000 |
| 2022/10/18 | 7,660 | 7,680 | 7,550 | 7,670 | +110 | +1.5% | 125,700 |
| 2022/10/17 | 7,690 | 7,690 | 7,520 | 7,560 | -190 | -2.5% | 176,700 |
| 2022/10/14 | 7,740 | 7,790 | 7,670 | 7,750 | +90 | +1.2% | 169,900 |
| 2022/10/13 | 7,670 | 7,720 | 7,610 | 7,660 | -10 | -0.1% | 136,300 |
| 2022/10/12 | 7,600 | 7,740 | 7,600 | 7,670 | +70 | +0.9% | 154,100 |
601～
650
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
